{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:29:28Z","timestamp":1780432168323,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T00:00:00Z","timestamp":1439337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.contraception.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T05:46:05Z","timestamp":1439185565000},"page":"280-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-7081","authenticated-orcid":false,"given":"Monica","family":"Dragoman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Gaffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.08.002_bb0005","series-title":"The Merck manual","article-title":"Dyslipidemia (hyperlipidemia)","author":"Goldberg","year":"2008"},{"key":"10.1016\/j.contraception.2015.08.002_bb0010","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2015.08.002_bb0015","series-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","author":"Stone","year":"2013"},{"key":"10.1016\/j.contraception.2015.08.002_bb0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejim.2007.10.019","article-title":"Venous and arterial thrombosis: different sides of the same coin?","volume":"19","author":"Franchini","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0889-8553(21)00513-6","article-title":"Hyperlipidemic pancreatitis","volume":"19","author":"Toskes","year":"1990","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.contraception.2015.08.002_bb0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.298.6680.1049","article-title":"Oral contraceptives and lipids","volume":"298","author":"Fotherby","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.08.002_bb0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20S","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0045","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0050","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","article-title":"Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study","volume":"183","author":"Gronich","year":"2011","journal-title":"CMAJ"},{"issue":"6 Pt 2","key":"10.1016\/j.contraception.2015.08.002_bb0055","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/0002-9378(92)91396-R","article-title":"The efficacy and tolerability of norgestimate\/ethinyl estradiol (250 micrograms of norgestimate\/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women","volume":"166","author":"Runnebaum","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0060","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/AOG.0b013e3181875ec5","article-title":"Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation","volume":"112","author":"Nelson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.contraception.2015.08.002_bb0070","first-page":"S204","article-title":"Stroke and TIA: epidemiology, risk factors, and the need for early intervention","volume":"14","author":"Fisher","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.contraception.2015.08.002_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.mcg.0000436438.60145.5a","article-title":"Issues in hypertriglyceridemic pancreatitis: an update","volume":"48","author":"Scherer","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.pan.2012.05.002","article-title":"A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose","volume":"12","author":"Lindkvist","year":"2012","journal-title":"Pancreatology"},{"key":"10.1016\/j.contraception.2015.08.002_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/alcalc\/agq088","article-title":"Severe hypertriglyceridemia influenced by alcohol (SHIBA)","volume":"46","author":"Bessembinders","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0090","doi-asserted-by":"crossref","first-page":"13-2","DOI":"10.1097\/MPA.0b013e31816074a1","article-title":"Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia","volume":"37","author":"Lloret Linares","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.contraception.2015.08.002_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1476-511X-10-157","article-title":"Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study","volume":"10","author":"Sandhu","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.contraception.2015.08.002_bb0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOL.0b013e3283319a1d","article-title":"Severe hypertriglyceridemia and pancreatitis: presentation and management","volume":"20","author":"Ewald","year":"2009","journal-title":"Curr Opin Lipidol"},{"issue":"6549","key":"10.1016\/j.contraception.2015.08.002_bb0105","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/bmj.293.6549.734","article-title":"Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinaemia","volume":"293","author":"Stuyt","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.contraception.2015.08.002_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2008-1055349","article-title":"Oral contraceptive-induced pancreatitis in the hyperchylomicronemia syndrome","volume":"120","author":"Schaefer","year":"1995","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.contraception.2015.08.002_bb0115","series-title":"Nelson textbook of pediatrics","author":"Kliegman","year":"2012"},{"key":"10.1016\/j.contraception.2015.08.002_bb0120","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM197309132891103","article-title":"Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy","volume":"289","author":"Davidoff","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0125","first-page":"75","article-title":"Estrogen-induced pancreatitis","volume":"2","author":"Parker","year":"1983","journal-title":"Clin Pharm"},{"key":"10.1016\/j.contraception.2015.08.002_bb0130","first-page":"161","article-title":"Hyperlipidaemia and pancreatitis associated with oral contraceptive therapy","volume":"23","author":"Mehrotra","year":"1975","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.contraception.2015.08.002_bb0135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/pgmj.46.539.576","article-title":"Case reports. Hyperlipaemic pancreatitis and the pill","volume":"46","author":"Bank","year":"1970","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.contraception.2015.08.002_bb0140","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults","volume":"285","author":"National Cholesterol Education Program Expert Panel","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2015.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2015.08.002_bb0150","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0002-9378(16)32487-5","article-title":"Effects of estrogens and progestogens on lipid metabolism","volume":"142","author":"Oster","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mob.2002.119179","article-title":"Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII","volume":"186","author":"van Rooijen","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.08.002_bb0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.contraception.2011.08.014","article-title":"Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism","volume":"85","author":"Guazzelli","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.08.002_bb0165","first-page":"179","article-title":"Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile","volume":"48","author":"Creasy","year":"2003","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2015.08.002_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0010-7824(00)00110-4","article-title":"Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns","volume":"61","author":"von Kesseru","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.08.002_bb0175","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:49:05Z","timestamp":1653018545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415005090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0010782415005090"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.08.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}